Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Brett

Showing results (361-370 of 413) with videos related to

Pageof 42
Sort By:
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2004
CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levelsUlrich A Maus, Sandra Wellmann, Christine Hampl, et al.
The Journal of Clinical Investigation|May 4, 2007
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionYan Shu, Steven A Sheardown, Chaline Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Clinical Neuropathology|March 31, 2026
Retrospective neuropathologic analysis of adult spinal tumors in a single neuroscience center 2018 - 2023Ciara O'Donoghue, Beibhinn Wilkins, Alan Beausang, et al.
Science Advances|October 23, 2015
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierJames Keaney, Dominic M Walsh, Tiernan O'Malley, et al.
Journal of Travel Medicine|January 13, 2026
Retrospective Analysis of Emerging Health Threats by Shoreland Travax®, 2019-2024Anna Carr Faurot, Tom Waters, Ayesha Iqbal, et al.
Molecular Pharmacology|August 26, 2006
Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)Thomas J Urban, Renata C Gallagher, Chaline Brown, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Pharmacogenetics and Genomics|June 2, 2009
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metforminYing Chen, Shuanglian Li, Chaline Brown, et al.
Molecular Cell|October 13, 2009
Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligasesMin Zhuang, Matthew F Calabrese, Jiang Liu, et al.
Pageof 42

Showing results (361-370 of 413) with videos related to

Sort By:
Pageof 42
American Journal of Physiology. Lung Cellular and Molecular Physiology|November 2, 2004
CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levelsUlrich A Maus, Sandra Wellmann, Christine Hampl, et al.
The Journal of Clinical Investigation|May 4, 2007
Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin actionYan Shu, Steven A Sheardown, Chaline Brown, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2006
Interaction of methotrexate with organic-anion transporting polypeptide 1A2 and its genetic variantsIlaria Badagnani, Richard A Castro, Travis R Taylor, et al.
Clinical Neuropathology|March 31, 2026
Retrospective neuropathologic analysis of adult spinal tumors in a single neuroscience center 2018 - 2023Ciara O'Donoghue, Beibhinn Wilkins, Alan Beausang, et al.
Science Advances|October 23, 2015
Autoregulated paracellular clearance of amyloid-β across the blood-brain barrierJames Keaney, Dominic M Walsh, Tiernan O'Malley, et al.
Journal of Travel Medicine|January 13, 2026
Retrospective Analysis of Emerging Health Threats by Shoreland Travax®, 2019-2024Anna Carr Faurot, Tom Waters, Ayesha Iqbal, et al.
Molecular Pharmacology|August 26, 2006
Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)Thomas J Urban, Renata C Gallagher, Chaline Brown, et al.
Clinical Pharmacokinetics|November 25, 2015
The Effect of Famotidine, a MATE1-Selective Inhibitor, on the Pharmacokinetics and Pharmacodynamics of MetforminJennifer E Hibma, Arik A Zur, Richard A Castro, et al.
Pharmacogenetics and Genomics|June 2, 2009
Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metforminYing Chen, Shuanglian Li, Chaline Brown, et al.
Molecular Cell|October 13, 2009
Structures of SPOP-substrate complexes: insights into molecular architectures of BTB-Cul3 ubiquitin ligasesMin Zhuang, Matthew F Calabrese, Jiang Liu, et al.
Pageof 42